Chief Physician, Professor, Doctoral Supervisor, Deputy Director of the Geriatric Medicine Center, and Deputy Director of the National Clinical Research Center for Geriatric Diseases
Affiliated HospitalWest China Hospital of Sichuan University
→
-Research areas : cognitive impairment in the elderly, delirium in the elderly; sarcopenia and frailty in the elderly; perioperative management of the elderly.
- Cutting-edge technologies: Early warning and non-pharmacological clustered intervention technology for delirium in hospitalized elderly patients; development of the world's first gene drug for sarcopenia (already in clinical trials); key technology system for the prevention and control of disability in the elderly (second prize of Huaxia Medical Science and Technology Award).
- Areas of expertise: Postoperative delirium in the elderly, cognitive impairment in hospitalized elderly, elderly at high risk of falls, delirium in the elderly, sarcopenia, frailty, perioperative management of the elderly.
- Academic Highlights: Academic leader in geriatric medicine at the Sichuan Provincial Health Commission; Visiting scholar at Harvard University; author of the Chinese expert consensus on delirium in the elderly; invited by the American Geriatrics Society (AGS) to participate in the development of guidelines for perioperative delirium in the elderly; participated in updating the Beer guidelines; published 23 SCI papers as first/corresponding author (including JAMA Internal Medicine), with research findings cited by NEJM and JAMA; invited to participate in the writing of AGS guidelines; 2 ESI highly cited papers, cited over 200 times by NEJM, JAMA, and BMJ; received the second prize of the Huaxia Medical Science and Technology Award and the second prize of the Sichuan Provincial Science and Technology Progress Award. Core Values: Internationally renowned scholar in the field of delirium in the elderly; established a delirium prevention and control program that can be promoted domestically.